StockData
Oramed Pharmaceuticals Inc. logo

Oramed Pharmaceuticals Inc. (ORMP) stock

ORMPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/30
$3.89+0.02 (+0.52%)

Close on Nov 18, 2026Market cap $161.81MP/E 0.9Yield 6.43%

Oramed Pharmaceuticals revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Oramed Pharmaceuticals's revenue for the twelve months ending Dec 31, 2025 was $2.00M. For fiscal 2025 it was $2.00M, up 49.3% from the year before. The highest annual figure on record is $2.71M in fiscal 2020.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.00M+49.3%
FY2023Dec 31, 2023$1.34M-50.4%
FY2021Aug 31, 2021$2.70M-0.3%
FY2020Aug 31, 2020$2.71M+0.3%
FY2019Aug 31, 2019$2.70M+10.4%
FY2018Aug 31, 2018$2.45M-0.3%
FY2017Aug 31, 2017$2.46M+283.2%
FY2016Aug 31, 2016$641.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2025CQ4 2025Dec 31, 2025$0–
Q3 FY2025CQ3 2025Sep 30, 2025$0–
Q2 FY2025CQ2 2025Jun 30, 2025$0-100.0%
Q1 FY2025CQ1 2025Mar 31, 2025$2.00M+200.3%
Q4 FY2023CQ4 2023Dec 31, 2023$0-100.0%
Q3 FY2023CQ3 2023Sep 30, 2023$0-100.0%
Q2 FY2023CQ2 2023Jun 30, 2023$674.00K+1.4%
Q1 FY2023CQ1 2023Mar 31, 2023$666.00K-1.2%
Q4 FY2021CQ3 2021Aug 31, 2021$683.00K+0.3%
Q3 FY2021CQ2 2021May 31, 2021$681.00K0.0%
Q2 FY2021CQ1 2021Feb 28, 2021$665.00K-1.3%
Q1 FY2021CQ4 2020Nov 30, 2020$674.00K0.0%
Q4 FY2020CQ3 2020Aug 31, 2020$681.00K0.0%
Q3 FY2020CQ2 2020May 31, 2020$681.00K-0.1%
Q2 FY2020CQ1 2020Feb 29, 2020$674.00K+9.2%
Q1 FY2020CQ4 2019Nov 30, 2019$674.00K+9.2%
Q4 FY2019CQ3 2019Aug 31, 2019$681.00K+12.7%
Q3 FY2019CQ2 2019May 31, 2019$682.00K+11.6%
Q4 FY2018CQ3 2018Aug 31, 2018$617.00K-0.2%
Q3 FY2018CQ2 2018May 31, 2018$617.00K0.0%
Q2 FY2018CQ1 2018Feb 28, 2018$604.00K-1.1%
Q1 FY2018CQ4 2017Nov 30, 2017$611.00K+0.2%
Q4 FY2017CQ3 2017Aug 31, 2017$618.00K-33.5%
Q3 FY2017CQ2 2017May 31, 2017$617.00K–
Q2 FY2017CQ1 2017Feb 28, 2017$611.00K+388.8%
Q1 FY2017CQ4 2016Nov 30, 2016$610.00K–
Q4 FY2016CQ3 2016Aug 31, 2016$929.00K–
Q3 FY2016CQ2 2016May 31, 2016-$163.00K–
Q2 FY2016CQ1 2016Feb 29, 2016$125.00K–

More Oramed Pharmaceuticals figures

See a number that looks wrong?